Core Insights - The EVO+ICL (V5) implant surgery, previously only available in Hainan, has now made significant progress in Jinan, allowing local patients to access advanced myopia correction technology [1] - The V5 crystal is designed to enhance night vision quality and reduce issues like glare and halos, representing a shift from merely correcting vision to optimizing visual quality [2] - Jinan Aier Eye Hospital has made substantial investments in technology upgrades, including the introduction of advanced laser and implant surgery equipment, demonstrating confidence in its capabilities [2][3] Technological Advancements - The V5 crystal's design significantly expands the optical zone, addressing common post-surgery issues and providing clear vision from day to night [2] - The hospital's recent upgrades include transitioning from the 3.0 to 4.0 version of femtosecond laser equipment and introducing the more advanced femtosecond Pro surgery [2] Service Innovations - The hospital has opened a consultation and reservation channel for the V5 implant surgery, allowing patients to undergo pre-operative assessments and customize their crystal parameters [4] - This initiative aims to streamline the process for patients, enabling them to secure their surgery dates and reduce waiting times once the technology is fully operational [4]

Core Viewpoint - The announcement from Guangzheng Eye Hospital regarding its board meeting and the discussion of related party transactions for 2026 indicates ongoing corporate governance and strategic planning efforts within the company [1]. Group 1: Company Announcements - Guangzheng Eye Hospital held its sixth board meeting on December 28, 2025, to review various documents, including the proposal for expected related party transactions for 2026 [1]. Group 2: Industry Developments - A new type of chip has been developed in China that bypasses the limitations of lithography machines, supporting AI training and embodied intelligence, and can be mass-produced using mature processes of 28 nanometers and above [1].

Core Viewpoint - Huaxia Eye Hospital announced the approval of several key resolutions during the 12th meeting of its third board of directors, including the election of the fourth board of directors and the termination of the 2025 employee stock ownership plan [1] Group 1 - The company approved the proposal for the election of non-independent director candidates for the fourth board of directors [1] - The company approved the proposal for the election of independent director candidates for the fourth board of directors [1] - The company decided to terminate the implementation of the 2025 employee stock ownership plan [1]

智通财经APP讯，朝聚眼科(02219)发布公告，于2025年12月29日该公司斥资27.03万港元回购10万股， 回购价格为每股2.66-2.71港元。 （原标题：朝聚眼科(02219)12月29日斥资27.03万港元回购10万股） ...

Group 1 - The company Huaxia Eye Hospital (301267) announced that it will hold its first extraordinary shareholders' meeting on January 14, 2026, at 14:30 [1] - The agenda includes the election of non-independent and independent directors by the board, utilizing a cumulative voting system [1] - The voting will be conducted both on-site and online [1]

Core Viewpoint - The company, Huaxia Eye Hospital (301267.SZ), has decided to terminate its employee stock ownership plan due to the impact of industry collective procurement policies and healthcare payment reform on its operations, which has led to a deviation from performance assessment indicators set for the plan [1] Group 1 - The company acknowledges that objective factors such as industry collective procurement policies and healthcare payment reform continue to affect its operations [1] - The company anticipates that the current business situation will not align with the performance assessment indicators of the employee stock ownership plan, making it difficult to achieve the intended motivational purpose and effect [1] - The decision to terminate the employee stock ownership plan was made after careful consideration of the long-term development of the company and the interests of employees, as well as the willingness of participating employees and the company's actual situation [1] Group 2 - The company’s board of directors has decided to terminate the implementation of the employee stock ownership plan ahead of schedule [1] - Along with the termination of the employee stock ownership plan, the company will also terminate related documents such as the "2025 Employee Stock Ownership Plan Management Measures" [1]

Group 1 - The core point of the article is that Huaxia Eye Hospital announced the termination of its 2025 employee stock ownership plan during its board meeting held on December 29, 2025 [1] - For the first half of 2025, Huaxia Eye Hospital's revenue composition is as follows: refractive services accounted for 36.9%, comprehensive optometry projects 24.04%, cataract services 20.14%, posterior segment projects 12.94%, and other businesses 5.99% [1] - As of the report date, Huaxia Eye Hospital has a market capitalization of 15.3 billion yuan [1]

华厦眼科(301267.SZ)年报显示，仙游华厦眼科医院有限公司，为公司子公司。 以下为原文： 中国经济网北京12月29日讯 信用中国网站显示，仙游华厦眼科医院有限公司信用信息新增一篇行政处罚决定书（仙市监处罚 ﹝2025﹞293号）。2025年9月10日，仙游县市场监督管理局接到福建省广告监测平台移交的违法广告线索，反映仙游华厦眼科医院 有限公司在微信"仙游华厦眼科"服务号发布违法广告。 2025年9月26日，仙游县市场监督管理局执法人员依法对仙游华厦眼科医院有限公司注册登记住所福建省莆田市仙游县鲤南镇城 南东路966号进行检查。执法人员现场打开微信"仙游华厦眼科"服务号，未发现发布有标题为"侨爱心点亮无声世界白内障手术助五保 户重获光明"的文章，当事人现场承认曾发布过该文章，现已删除，提供了1份文章删除截图。当事人的行为涉嫌违反《医疗广告管理 办法》的有关规定，建议立案调查。 依据《医疗广告管理办法》第二十二条的规定，仙游县市场监督管理局责令当事人改正上述违法行为，对当事人仙游华厦眼科医 院有限公司作如下行政处罚：对当事人发布利用患者、卫生技术人员形象作证明的医疗广告的违法行为，处罚款人民币5000元。以 ...

Core Viewpoint - The strategic cooperation between Sun Yat-sen University Zhongshan Ophthalmic Center and Guangdong Hengjian Investment Holdings aims to enhance technological innovation and industrial transformation in the ophthalmology field, establishing a high-level collaborative innovation platform. Group 1: Strategic Cooperation Details - A strategic cooperation framework agreement was signed between Sun Yat-sen University Zhongshan Ophthalmic Center and Guangdong Hengjian Investment Holdings [1][3] - The partnership will focus on five key areas: establishing the "Guangdong Smart Ophthalmology and Vision Health Industry Innovation Application Center," creating a technology research and transformation platform, exploring the establishment of an innovation joint fund, innovating the technology transfer mechanism, and promoting quality ophthalmic technology to rural areas [3][4] Group 2: Goals and Expectations - The cooperation aims to accelerate the development of new productive forces in the ophthalmology field by integrating clinical resources, research capabilities, and industrial capital [3] - The initiative is expected to enhance the success rate of scientific research results transformation and shorten the transformation cycle [4] - The collaboration will create a new mechanism for transforming research results by integrating six elements: government, industry, academia, research, application, and capital [4]

Core Viewpoint - He Eye Hospital (301103.SZ) is celebrating its 30th anniversary by launching an "Investor Health Feedback Activity" to establish a long-term and diverse shareholder return mechanism, expressing gratitude to shareholders for their ongoing support and trust [1] Group 1: Investor Engagement - The company will provide each participating shareholder with a dedicated eye health service consultant to offer "full-process convenient services" [1] - Discounts will be available on optical products such as orthokeratology lenses, myopia management lenses, and frame glasses [1] - Exclusive discounts on diagnostic projects including eye-brain visual training, genetic testing, and meibomian gland massage therapy will be offered [1] Group 2: Surgical and Aesthetic Services - Shareholders will receive exclusive discounts on myopia correction refractive surgeries [1] - Aesthetic medical projects will also be included in the offerings [1] - Special eye health check-up plans will be available for shareholders [1]